KR20040039837A - artemia cysts and treatment method of thereof - Google Patents
artemia cysts and treatment method of thereof Download PDFInfo
- Publication number
- KR20040039837A KR20040039837A KR1020020068054A KR20020068054A KR20040039837A KR 20040039837 A KR20040039837 A KR 20040039837A KR 1020020068054 A KR1020020068054 A KR 1020020068054A KR 20020068054 A KR20020068054 A KR 20020068054A KR 20040039837 A KR20040039837 A KR 20040039837A
- Authority
- KR
- South Korea
- Prior art keywords
- eggs
- althemia
- water
- protective film
- egg
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 241001247197 Cephalocarida Species 0.000 title abstract 3
- 208000031513 cyst Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 31
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 230000001681 protective effect Effects 0.000 claims abstract description 25
- 239000011248 coating agent Substances 0.000 claims abstract description 15
- 238000000576 coating method Methods 0.000 claims abstract description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 5
- 235000013343 vitamin Nutrition 0.000 claims abstract description 5
- 239000011782 vitamin Substances 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 5
- 235000013601 eggs Nutrition 0.000 claims description 55
- 210000003278 egg shell Anatomy 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000003623 enhancer Substances 0.000 claims description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 12
- 102000002322 Egg Proteins Human genes 0.000 claims description 11
- 108010000912 Egg Proteins Proteins 0.000 claims description 11
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 229940021747 therapeutic vaccine Drugs 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 230000001571 immunoadjuvant effect Effects 0.000 claims description 2
- 239000000568 immunological adjuvant Substances 0.000 claims description 2
- 229960001438 immunostimulant agent Drugs 0.000 claims description 2
- 239000003022 immunostimulating agent Substances 0.000 claims description 2
- 230000003308 immunostimulating effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000011241 protective layer Substances 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 230000035764 nutrition Effects 0.000 abstract description 6
- 238000003672 processing method Methods 0.000 abstract description 6
- 229960005486 vaccine Drugs 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 239000012744 reinforcing agent Substances 0.000 abstract 3
- 241000251468 Actinopterygii Species 0.000 description 13
- 230000012447 hatching Effects 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000091 immunopotentiator Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/80—Feeding devices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Environmental Sciences (AREA)
- Birds (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Fodder In General (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
Description
본 발명은 알테미아 알의 가공방법에 관한 것으로서, 보다 상세하게는 양식 중인 치어에게 면역강화제를 비롯한 기타 약제들을 효과적으로 공급할 수 있는 새로운 구성의 알테미나 알 및 그 가공방법에 관한 것이다.The present invention relates to a method for processing althemia eggs, and more particularly, to a new configuration of altena eggs and a method for processing the same, which can effectively supply an immunopotentiator and other drugs to aquaculture fry.
최근에는 어자원의 격감으로 인해 잡는 어업에서 기르는 어업으로의 전환이 빠른 속도로 진행되고 있고, 이에 따라 양식어업이 상당히 발전하고 있다. 그리고 식용 또는 관상어 등의 양식과정에 있어서, 알에서 갓 부화된 치어는 소화기능과 면역기능이 약하기 때문에 폐사가능성이 높다. 따라서 치어가 폐사하는 것을 방지하고, 성장된 치어를 가두리양식장과 같은 자연조건하의 양식장으로 옮겼을 때 건강하게 자라도록 하기 위해서는 치어의 먹이를 세심하게 선택하여야 한다. 현재까지 이러한 치어의 먹이로는 알테미아의 유충이 최상의 먹이로 알려져 있다.In recent years, the transition from catching fish to growing fishery has been progressing rapidly due to the drastic reduction of fish stocks. And in the cultivation process, such as edible or ornamental fish, freshly hatched fry from eggs are more likely to die because of weak digestive and immune functions. Therefore, in order to prevent the fry from being killed and to grow healthy when the larvae are moved to the farm under natural conditions such as cage farms, the fry's food must be carefully selected. To this day, the larvae of Althemia are known as the best foods for fry.
알테미아는 대략 염도 70ppt정도의 염호에서 생존하기 때문에, 알테미아 알은 극히 제한된 지역에서만 제공되며, 염호에서 수집된 알은 가공처리되어 최종소비지인 각 양식장으로 공급된다. 이러한 알테이마 알은 건조, 한냉, 진공 등에 강한 내성을 가지고 있으며, 약 10% 이하로 수분이 제거된 상태에서는 수면상태가 되어 대사활동이 정지된다. 그리고 다시 수분을 흡수하면, 대사활동이 진행되어 대략 24∼48시간 만에 부화하게 된다. 이러한 알테미아 알은 도 1에 도시된 바와 같이,배아(1)를 감싸고 있는 유충표피(2)의 외측에 외부표피막(4)이 있고, 이 외부표피막(4)의 외측을 난각(6)이 싸고 있는 구조로 되어 있다.Because Althemia survives in approximately 70 ppt of saltwater, Althemia eggs are provided only in very limited areas, and the eggs collected in the saltwater are processed and fed to each farm for final consumption. These altima eggs have a strong resistance to drying, cold, vacuum, etc., and when the water is removed to less than about 10%, the metabolic activity is stopped due to sleep. When the water is absorbed again, metabolic activity proceeds to hatch in approximately 24 to 48 hours. As shown in FIG. 1, the Althemia egg has an outer epidermis 4 on the outer side of the larva epidermis 2 surrounding the embryo 1, and an egg shell 6 on the outside of the outer epidermis 4. This is a cheap structure.
상기 난각(6)은 외부의 충격과 자외선으로부터 배아(1)를 보호하는 역할을 하는데, 건조된 알이 부화되는 과정에서 알테미아의 유충이 딱딱한 난각(6)을 터뜨리고 나와야 하므로 부화시 유충의 에너지소비가 많다. 따라서 치어가 영양이 손실된 알테미아의 유충을 섭취하게 되므로 영양적으로 상당한 손실이 따른다. 뿐만 아니라 갓 부화된 알테미아 유충은 난각(6)을 달고 다니기도 하는데, 치어가 알테미아 유충을 먹을 때 난각(6)을 함께 먹으면 소화기 장애를 일으킨다.The egg shell (6) serves to protect the embryo (1) from external shocks and ultraviolet rays, because the larvae of althemia must burst the hard egg shell (6) during the hatching of dried eggs, the energy of the larva during hatching High consumption Therefore, the larvae eat larvae of malnutrition that have lost nutrition, so nutritional loss is significant. In addition, freshly hatched Altemia larvae also carry eggshells (6), and when the fry eat the eggs, the eggshells (6) cause digestive problems.
한편, 알테미아 알의 가공방법 중에는 난각을 제거하여 진공포장하는 방법이 있다. 이 방법은 전술한 바와 같이 난각(6)에 의해 발생되는 문제점이 해소되기는 하나, 난각이 제거된 알테미아 알은 유통기간이 1∼2개월에 지나지 않을 뿐만 아니라, 유통과정에서 치사되는 확률이 상당히 높은 단점이 있다. 그리고 이러한 가공방법의 문제점을 해결하고자 본원인은 난각이 제거된 알테미아 알에 인공보호막을 코팅하여 가공하는 방법을 제안한 바 있다(특허출원 제2000-74362호).On the other hand, among the processing methods of Althemia egg, there is a method of vacuum packaging by removing the egg shell. This method solves the problems caused by the egg shell 6 as described above, but the egg-free Althemia eggs not only have a shelf life of 1 to 2 months, but also have a high probability of being killed in distribution. There are disadvantages. In order to solve the problem of the processing method, the present applicant has proposed a method for processing by coating an artificial protective film on the egg of Althemia eggs from which egg shells have been removed (Patent Application No. 2000-74362).
또한, 양어장 등에서 치어의 영양을 강화시키거나 질병치료 등을 위해 각종 약제를 공급하기도 하는데, 이러한 경우에 종래에는 치어가 양어장의 물을 통해 약제를 섭취하도록 양어장에 약제를 그냥 투입한다. 그러나 이 경우에는 약제가 물에 희석되므로 상당히 많은 양의 약품을 투입하여야 하며 이에 따라 비용상승이 초래되었다. 또한, 이와 같이 양어장에 약제를 직접 투입하는 경우에는 실제 치어가 섭취하는 약제의 양보다 버려지는 약제의 양이 훨씬 더 많으므로 약제의 낭비가 심하다. 뿐만 아니라 이 경우에는 약제가 양어장 바닥에 가라앉아 장기간 잔존하게 되면 약제가 변질되면서 양어장이 오염되고, 치어에게도 악영향을 미친다.In addition, in the fish farm, etc. may also supply a variety of drugs for strengthening the nutrition of the fry or for treating diseases, in which case conventionally just put the medicine in the fish farm so that the fry take the medicine through the water of the fish farm. However, in this case, since the drug is diluted in water, a large amount of the drug must be injected, resulting in a cost increase. In addition, in the case of directly injecting the drug into the fish farm, the amount of the discarded drug is much higher than the amount of the drug actually consumed by the fish is a waste of the drug. In addition, in this case, if the drug sinks to the bottom of the fish farm and remains for a long time, the drug is deteriorated and the fish farm is contaminated.
본 발명은 상기의 문제점에 착안하여 제안된 것으로서, 본 발명의 목적은 알테미아 알을 부화시켜 그 유충을 치어에게 공급하는 단순한 급이과정을 통해 약제들을 효과적으로 공급할 수 있으므로 별도로 약제를 공급할 필요가 없으며, 치어들의 약제 섭취효율도 상승되는 새로운 구성의 알테미아 알 및 그 가공방법을 제공하는 것이다.The present invention has been proposed in view of the above problems, and an object of the present invention is to supply the drugs through a simple feeding process of hatching the althemia eggs and supplying the larvae to the fry, so there is no need to supply drugs separately. It is to provide a new composition of althemia eggs and its processing method to increase the drug intake efficiency of the fry.
도 1은 일반적인 알테미아 알의 구성을 보인 부분 확대단면도1 is a partially enlarged cross-sectional view showing the configuration of a typical Althemia egg
도 2는 본 발명에 의한 알테미아 알의 구성을 보인 부분확대단면도Figure 2 is a partially enlarged cross-sectional view showing the configuration of Althemia eggs according to the present invention
<도면의 주요부분에 대한 부호의 설명><Description of the symbols for the main parts of the drawings>
1. 배아 2. 유충표피1. Embryo 2. Larva Epidermis
4. 외부표피막 10. 인공보호막4. Outer epidermal film 10. Artificial protective film
본 발명에 따르면, 배아(1)와, 상기 배아(1)를 감싸도록 수용성코팅제로 코팅된 인공보호막(10)을 포함하는 알테미나 알에 있어서, 상기 인공보호막(10)에는 면역강화제와 치료백신제, 영양강화제 중에서 선택된 적어도 하나 이상의 약제가 혼합되며, 상기 영양강화제는 비타민, 불포화지방산 및, Se, Co, Zn, Mn 중에서 하나 또는 그 이상으로 선택되는 것을 특징으로 하는 알테미아 알이 제공된다.According to the present invention, in the alumina egg comprising an embryo (1) and an artificial protective film (10) coated with a water-soluble coating agent to surround the embryo (1), the artificial protective film (10) is treated with an immunostimulant At least one agent selected from a vaccine and a nutrient enhancer is mixed, and the nutrient enhancer is provided with vitamins, unsaturated fatty acids and one or more selected from Se, Co, Zn, and Mn.
본 발명의 다른 특징에 따르면, 건조된 알테미아 알을 물에 투입하여 알테미아 알의 함수률을 높이는 과정과, 물을 흡수한 알테미아 알을 탈각용액에 투입하여알테미아 알의 난각(6)을 용해시켜 제거하는 과정과, 난각(6)이 제거된 알테미아알을 건조시키는 과정과, 상기 건조된 알테미아 알의 표면을 수용성코팅제로 코팅하여 인공보호막(10)을 형성하는 과정을 포함하여 이루어지는 알테미아 알의 가공방법에 있어서, 상기 인공보호막(10)을 코팅하는 과정에서는 기재인 수용성코팅제에 면역강화제와, 치료백신제, 영양강화제 중에서 선택된 적어도 하나 이상의 약제를 혼합하여 인공보호막(10)을 형성하며, 상기 영양강화제는 비타민, 불포화지방산 및 Se, Co, Zn, Mn 중에서 하나 또는 그 이상으로 선택되는 것을 특징으로 하는 알테미아 알의 가공방법이 제공된다.According to another feature of the present invention, the process of increasing the water content of Althemia eggs by adding the dried Althemia eggs to water, and by adding Althemia eggs absorbed with water to the deshelling solution to dissolve and remove the egg shell (6) of Althemia eggs And a step of drying the eggplant egg from which the eggshell 6 has been removed, and a step of forming the artificial protective film 10 by coating the surface of the dried eggemia egg with a water-soluble coating agent. In the process of coating the artificial protective film 10, an artificial protective film (10) is formed by mixing at least one agent selected from an immunoadjuvant, a therapeutic vaccine and a nutrition enhancer to a water-soluble coating agent as a base material, the nutritional enhancer Is a vitamin, unsaturated fatty acid and Se, Co, Zn, Mn is a processing method of Althemia egg, characterized in that it is selected from one or more of Ball.
이하, 본 발명을 상세히 설명하면 다음과 같다. 본 발명은 도 2에 도시된 바와 같이, 배아(1)와, 이 배아(1)를 감싸도록 코팅된 인공보호막(10)을 포함하는 알테미아 알로서, 상기 배아(1)와 인공보호막(10) 사이에는 유충표피(2)와, 유충표피막(4) 등의 내부막이 있다. 이러한 본 발명에 의한 알테미아 알은 다음과 같이 제조된다.Hereinafter, the present invention will be described in detail. As shown in FIG. 2, the present invention provides an embryo of Althemia comprising an embryo 1 and an artificial protective film 10 coated to surround the embryo 1, wherein the embryo 1 and the artificial protective film 10. In between are larvae epidermis 2 and inner membranes such as larvae epidermis 4. Althemia eggs according to the present invention are prepared as follows.
염호에서 수집된 알테미아의 알은 건조된 상태로서, 양쪽이 오목하게 찌그러진 모양을 가진다. 본 발명에서는 먼저, 건조된 알테미아 알을 물에 투입하여 알의 함수율을 높인다. 알테미아 알을 물에 넣으며 알이 물을 흡수하면서 구형으로 팽창한다. 그런 다음 상기 수화된 알테이마 알을 Ca(ClO)2또는 Na2CO3와 같은 탈각용액에 투입하여 알테미아 알의 난각을 용해시킨다. 이때에는 알테미아 알을 탈각용액에 대략 15∼20분 정도 넣어 두는데, 상기 탈각용액 내로 공기를 주입하면서 처리하여 알테미아의 알이 고르게 처리되도록 한다. 이와 같이 하여 알테미아 알의 난각을 제거하면, 배아(1)를 감싸고 있는 내부막이 외부로 노출된다.The eggs of Altemia collected in the salt lake are dried and have a concave and dent shape on both sides. In the present invention, first, the dried althemia eggs are added to water to increase the water content of the eggs. Altemia eggs are placed in water and the eggs expand into a sphere as they absorb water. Then, the hydrated altema egg is added to a deshelling solution such as Ca (ClO) 2 or Na 2 CO 3 to dissolve the egg shell of Althemia egg. At this time, the Althemia eggs are placed in the shelling solution for about 15 to 20 minutes, and the air is injected into the shelling solution so that the eggs of Althemia are treated evenly. In this way, when the eggshell of the Althemia egg is removed, the inner film surrounding the embryo 1 is exposed to the outside.
이어서 탈각된 알테미아 알을 함수율이 10% 이하 정도 되도록 건조시킨 다음, 건조된 알의 표면을 수용성코팅제로 코팅하여 인공보호막(10)을 만든다. 상기 수용성코팅제는 의약품이나 식품 등의 캡슐제재로 흔히 사용되는 것으로, 예를 들면 젤라틴, HMPC(Hydroxypropyl- methylcellulose), 유당, 키토산, 알긴산, 산화전분 등이 있다.Subsequently, the shelled althemia eggs are dried to have a water content of about 10% or less, and then the surface of the dried eggs is coated with a water-soluble coating agent to form an artificial protective film 10. The water-soluble coating agent is commonly used in capsules, such as pharmaceuticals and foods, for example, gelatin, HMPC (Hydroxypropyl methylcellulose), lactose, chitosan, alginic acid, starch oxide and the like.
본 발명에서는 상기 인공보호막(10)에 면역강화제, 치료백신제, 영양강화제 등이 혼합된다. 상기 면역강화제로는 베타-1,3-글루칸, 베타-1,3-1,6글루칸, 펩티드 글리칸을 비롯하여 기타 면역다당류 등이 사용되며, 치료백신으로는 비브리오 백신 등이 사용된다. 또, 영양강화제로는 비타민C, 비타민E 또는 불포화지방산, 미량의 Se, Co, Zn, Mn 등이 사용된다. 그리고 인공보호막(10)을 코팅할 때에는 상기 약제들을 하나 또는 그 이상으로 선택하고 기재인 수용성코팅제에 선택된 약제들을 액상 또는 분말상으로 혼합하여 외부표피막(4)에 코팅한다. 이상과 같이 하여 인공보호막(10)이 코팅된 알테미아 알은 진공포장된다.In the present invention, the artificial protective film 10 is mixed with an adjuvant, therapeutic vaccine, nutrient enhancer and the like. As the immunopotentiator, beta-1,3-glucan, beta-1,3-1,6 glucan, peptide glycan and other immunopolysaccharides are used, and as a therapeutic vaccine, a vibrio vaccine is used. In addition, vitamin C, vitamin E or unsaturated fatty acids, trace amounts of Se, Co, Zn, Mn, and the like are used as nutrition enhancers. When the artificial protective film 10 is coated, one or more of the above-mentioned drugs are selected, and the drugs selected for the water-soluble coating agent as a base material are mixed in a liquid or powder form and coated on the outer epidermal film 4. As described above, the Althemia eggs coated with the artificial protective film 10 are vacuum packed.
이상과 같은 방법으로 가공된 알테미아 알을 치어의 먹이로 제공하는 경우에는 알테미아 알을 부화조에서 부화시킨 다음, 부화된 유충을 치어에게 공급한다. 알테미아 알이 부화조에서 물을 흡수하면 정지되었던 대사활동이 시작되고, 약 18~24시간 정도 후에 부화된다. 이때 상기 인공보호막(10)은 수용성이여서 부화조에서 용해되어 저절로 제거되므로 알테미아 유충이 부화시 인공보호막(10)을 뚫고나와야 하는 노력을 하지 않아도 된다. 그리고 인공보호막(10)이 용해됨에 따라 인공보호막(10)에 함유되어 있던 약제들은 부화조의 물에 혼합되며, 부화된 알테미아 유충이 이 약제들을 흡입하게 된다. 따라서 치어가 이러한 알테미아 유충을 먹으면, 치어는 먹이와 함께 상기 약제들은 동시에 섭취하게 된다.In the case of providing the altemia eggs processed as described above to feed the fry, the eggs are hatched in the hatching tank, and then the hatched larvae are fed to the fry. When Althemia eggs absorb water from the hatchery, the metabolic activity, which has stopped, begins, and hatches after about 18 to 24 hours. In this case, since the artificial protective film 10 is water-soluble, it is dissolved in the hatching tank and removed by itself, so that the Artemisia larvae do not have to make an effort to penetrate the artificial protective film 10 during hatching. And as the artificial protective film 10 is dissolved, the drugs contained in the artificial protective film 10 are mixed in the water of the incubation tank, and the hatched Altemia larvae inhale these drugs. Thus, when a fry eats these Artemisia larvae, the fry take the medication simultaneously with the food.
이상과 같은 본 발명에 의한 알테미아 알을 사용하는 경우에는 알테미아 알을 부화시켜 치어에게 제공하는 단순한 급이과정에서 인공보호막에 함유된 약제들이 치어에게 공급되므로 치어에게 약제를 공급하는 별도의 작업이 필요 없을 뿐만 아니라 양어장에 약제를 직접 투입하는 종래에 비해 치어의 약제 섭취효율도 상승되며, 양어장에 잔존하는 약제에 의해 양어장이 오염될 우려도 없다.In the case of using the Althemia eggs according to the present invention as described above, since the drugs contained in the artificial protective film are supplied to the fry during the simple feeding process of hatching the Althemia eggs and providing them to the fry, a separate operation of supplying the medicaments to the fry is necessary. In addition, compared to the conventional injecting the drug directly into the fish farm, the drug intake efficiency of the fry is also increased, there is no fear that the fish farm is contaminated by the remaining drugs in the fish farm.
이상에서와 같이 본 발명에 의하면, 알테미아 알의 난각 대신 면역강화제, 치료백신제, 영양강화제 등이 혼합된 인공보호막(10)이 코팅된 새로운 구성의 알테미아 알 및 그 가공방법이 제공된다. 이러한 본 발명에 의한 알테미아 알을 사용하는 경우에는 양식업자들은 알테미아 알을 부화시킨 후, 그 유충을 치어에게 공급하기만 하면 되므로 종래에 약제를 구입하고 이 약제들은 치어에게 공급하는 별도의 작업을 하지 않아도 된다. 따라서 양식업자들의 작업량이 줄고 약제 구입비용도 절감되어 원가절감효과를 얻을 수 있을 뿐만 아니라 치어들이 약제를 섭취하는 효율도 상승되므로 치어들을 건강하게 양식할 수 있다.As described above, according to the present invention, there is provided a new composition of althemia eggs coated with an artificial protective film 10 in which an immune enhancer, a therapeutic vaccine agent, a nutrient enhancer, etc., are mixed instead of the egg shell of the althemia egg, and a processing method thereof. In the case of using the Altemia eggs according to the present invention, the aquaculture farmers hatch the Altemia eggs and then supply the larvae to the larvae. You don't have to. As a result, farmers can reduce their workload and reduce the cost of drug purchases, resulting in cost savings.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020068054A KR20040039837A (en) | 2002-11-05 | 2002-11-05 | artemia cysts and treatment method of thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020068054A KR20040039837A (en) | 2002-11-05 | 2002-11-05 | artemia cysts and treatment method of thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20040039837A true KR20040039837A (en) | 2004-05-12 |
Family
ID=37337358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020020068054A KR20040039837A (en) | 2002-11-05 | 2002-11-05 | artemia cysts and treatment method of thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20040039837A (en) |
-
2002
- 2002-11-05 KR KR1020020068054A patent/KR20040039837A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lim et al. | Astaxanthin as feed supplement in aquatic animals | |
| CN102150757B (en) | Aquatic product feed additive composition, preparation method and application thereof | |
| US20040009160A1 (en) | Bioactive food complex, method for making bioactive food complex product and method for controlling disease | |
| JP2003505049A (en) | Larval cultivation method and apparatus for crustaceans | |
| KR20100100808A (en) | Fish food capsule | |
| WO2002000035A1 (en) | Bioactive food complex, method for making bioactive food complex product and method for controlling disease | |
| US20130337030A1 (en) | Neutrally buoyant ingestible compositions | |
| KR101568466B1 (en) | Feed composite for curturing broodstork of eel | |
| CN109170162A (en) | A kind of cray artificial breeding formula forage | |
| CN106376723A (en) | Special feed for breeding broiler chickens | |
| KR20170117749A (en) | An aquarium fish feed composition comprising hermetia illucens and aloe and its preparing method | |
| KR20040039837A (en) | artemia cysts and treatment method of thereof | |
| KR20190076979A (en) | Feeds and methods for making them | |
| JP2000281568A (en) | Agent for preventing and curing parasite | |
| JP2002199848A (en) | Formulated feed for aquatic invertebrate | |
| CN105815602A (en) | Bait for high-yield crawfish | |
| KR100376402B1 (en) | treatment method of artemia cysts | |
| CN106858056A (en) | Bostrichthys sinensis feed containing medicinal herb componentses and preparation method thereof | |
| Yousefian et al. | Investigation of survival, growth and biochemical blood parameters of common carp (Cyprinus carpio L.) larvae fed by artificial diets | |
| CN109198164A (en) | A kind of soft-shelled turtle feed and preparation method thereof | |
| CN108813113A (en) | A kind of mixed feed and preparation method thereof promoting polysaccharide synthesis in sea cucumber body | |
| KR20200119265A (en) | Cephalopod feeding device, feeding method and cephalopod | |
| Dlaza | Growth of juvenile abalone under aquaculture conditions | |
| CN107347807A (en) | A kind of cultural method of flame tortoise | |
| Jabbar et al. | Nanocalcium of Pila ampullacea Shell incorporated into Feed on Molting and Growth Performance of Crayfish Cherax quadricarinatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| NORF | Unpaid initial registration fee |